In men with castration-resistant prostate cancer, explains Neal D. Shore, MD, FACS, the first sentinel prognostic event is often a bone metastasis. A key goal in treatment is to prevent bone metastases from the outset. The degree of symptoms resulting from bone lesions can vary greatly across men. Skeletal-related events associated with these bone metastases may need different types of palliative or therapeutic treatment
